This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Luo, J.-L. Articles by Hollstein, M. Search for Related Content PubMed PubMed Citation Articles by Luo, J.-L. Articles by Hollstein, M.

UV-induced DNA Damage and Mutations in Hupki (Human p53 Knock-in) Mice Recapitulate p53 Hotspot Alterations in Sun-exposed Human Skin¹

German Cancer Research Center, D69120 Heidelberg, Germany [J-L. L., M. He., R. K., Q. Y., M. Ho.]; IARC, F-69372 Lyon France [W-M. T., D. G., Z-Q. W.]; and Beckman Research Institute, City of Hope, Duarte California [J-H. Y., G. P. P.]

The major etiological agent contributing to human nonmelanoma skin cancer is sunlight. The p53 tumor suppressor gene is usually mutated in these tumors, and the mutations are "UV signature" single or tandem transitions at dipyrimidine sequences in the DNA-binding domain (DBD). Cells that harbor these characteristic mutations are already present in sun-exposed skin areas of healthy individuals, and small epidermal patches that are immunoreactive to anti-p53 antibody accrue as exposure increases. To explore carcinogen-specific human p53 mutation patterns experimentally, we generated a knock-in (Hupki) mouse in which the murine DBD of the p53 gene has been replaced by the homologous human p53 DBD segment; thus, the precise base sequence context frequently targeted by mutagens or endogenous mutagenic processes in human carcinogenesis is present in this strain (J. L. Luo et al., Oncogene, 20: 320–328, 2001). Here we show that when epidermal cells of Hupki mice (p53^ki/ki) are irradiated in vivo with a single acute dose of UVB light, they accumulate UV photoproducts at the same locations of the p53 gene as human cells. Chronic exposure of Hupki mice (4.5 kJ/m² 5x/week for 4 weeks) results in the appearance of cell patches that stain intensely with the anti-p53 antiserum CM1. DNA preparations from 2 cm² sections of chronically irradiated Hupki epidermis harbor C to T and CC to TT mutations at two mutation hotspots identified in human skin cancer, one at codons 278–279, and one at codons 247–248; the latter is the most frequent UVB-associated mutation site in humans but not in p53 wild-type mice. Thus, Hupki keratinocytes with these p53 mutations encode an aberrant DBD identical in amino acid sequence to the mutant p53 molecules in human UV-induced tumors. The Hupki mouse model offers a new experimental tool in molecular epidemiology and biomedical research.

This article has been cited by other articles:

				J. vom Brocke, A. Krais, C. Whibley, M. C. Hollstein, and H. H. Schmeiser The carcinogenic air pollutant 3-nitrobenzanthrone induces GC to TA transversion mutations in human p53 sequences Mutagenesis, January 1, 2009; 24(1): 17 - 23. [Abstract] [Full Text] [PDF]

				C. Dudgeon, C. Kek, O. N. Demidov, S.-i. Saito, K. Fernandes, A. Diot, J.-C. Bourdon, D. P. Lane, E. Appella, A. J. Fornace Jr., et al. Tumor Susceptibility and Apoptosis Defect in a Mouse Strain Expressing a Human p53 Transgene. Cancer Res., March 15, 2006; 66(6): 2928 - 2936. [Abstract] [Full Text] [PDF]

				V. M. Arlt 3-Nitrobenzanthrone, a potential human cancer hazard in diesel exhaust and urban air pollution: a review of the evidence Mutagenesis, November 1, 2005; 20(6): 399 - 410. [Abstract] [Full Text] [PDF]

				M. Jaworski, S. Hailfinger, A. Buchmann, M. Hergenhahn, M. Hollstein, C. Ittrich, and M. Schwarz Human p53 knock-in (hupki) mice do not differ in liver tumor response from their counterparts with murine p53 Carcinogenesis, October 1, 2005; 26(10): 1829 - 1834. [Abstract] [Full Text] [PDF]

				Z. Liu, K.-R. Muehlbauer, H. H. Schmeiser, M. Hergenhahn, D. Belharazem, and M. C. Hollstein p53 Mutations in Benzo(a)Pyrene-Exposed Human p53 Knock-in Murine Fibroblasts Correlate with p53 Mutations in Human Lung Tumors Cancer Res., April 1, 2005; 65(7): 2583 - 2587. [Abstract] [Full Text] [PDF]

				Z. Liu, M. Hergenhahn, H. H. Schmeiser, G. N. Wogan, A. Hong, and M. Hollstein Human tumor p53 mutations are selected for in mouse embryonic fibroblasts harboring a humanized p53 gene PNAS, March 2, 2004; 101(9): 2963 - 2968. [Abstract] [Full Text] [PDF]

				S. Schubert, B. Skawran, F. Dechend, K. Nayernia, A. Meinhardt, I. Nanda, M. Schmid, W. Engel, and J. Schmidtke Generation and Characterization of a Transgenic Mouse with a Functional Human TSPY Biol Reprod, September 1, 2003; 69(3): 968 - 975. [Abstract] [Full Text] [PDF]